Category: Business and Investments
Trubion reports positive data from Phase 2B TRU-015 study
Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) announced favorable safety and efficacy data following administration of a …
Rexahn reports Phase IIa data for Serdaxin
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN) announced top-line results from a Phase IIa clinical study …
Endocyte announces close of $26 million equity financing
Endocyte, Inc., completed a $26 million extension of its Series C financing. This round included …
Targacept reports positive Phase 2b trial results for depression treatment
Targacept, Inc. (NASDAQ: TRGT) presented data from its Phase 2b clinical trial of TC-5214 as …
Q&A with ExonHit Therapeutics’ Loïc Maurel, MD
We recently spoke with Loïc Maurel, M.D., president of ExonHit Therapeutics’ Management Board, one of …
Inovio begins HIV clinical trial of DNA vaccine
Inovio Biomedical Corporation (NYSE Amex: INO) and the HIV Vaccine Trials Network (HVTN) initiated a …
Methylgene to receive equity investment from Otsuka Pharmaceutical
MethylGene Inc. (TSX: MYG) agreed to issue 3,686,182 common shares to Otsuka Pharmaceutical Co., Ltd. …
Provectus starts compassionate use program for PV-10
Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) expanded its compassionate use program for PV-10, making the agent, …
Positive Palifosfamide Sarcoma Phase II Data from ZIOPHARM
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced positive data from the multicenter randomized Phase II trial …
Positive clinical trial results for Epeius
Epeius Biotechnologies Corporation announced results of its Rexin-G® clinical trials. Administered as stand-alone therapy in …